← Back to Search

Nausea Relief Inhaler for Post-Operative Nausea and Vomiting

N/A

Recruiting

Led By Ashley Attaway, RN

Research Sponsored by Methodist Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 to 65 years old

Admitted to B4 surgical acute unit

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of hospital stay: date of discharge minus date of admittance)

Awards & highlights

Study Summary

This trial suggests that a nausea relief inhaler could reduce post-op nausea and vomiting after bariatric surgery, improving patient satisfaction and ability to ambulate.

Who is the study for?

This trial is for individuals aged 18 to 65 who are undergoing bariatric surgery after May 31st, 2020. Participants must attend a pre-op class and read English. It's not for those on pre-op nausea meds, with a BMI over 60, allergies to certain natural scents, or with asthma/COPD.Check my eligibility

What is being tested?

The study tests if a nausea relief inhaler can reduce post-operative nausea and vomiting in patients after bariatric surgery. The goal is to see if this method decreases the need for additional medications and improves patient recovery experience.See study design

What are the potential side effects?

Potential side effects of the nausea relief inhaler may include reactions to its natural ingredients like spearmint, lemon, ginger, or cedarwood. However, these are expected to be minimal compared to traditional medication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I am admitted to the B4 surgical acute unit.

Select...

I will attend the pre-operative class.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ "up to 24 hours"

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~"up to 24 hours"

This trial's timeline: 3 weeks for screening, Varies for treatment, and "up to 24 hours" for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medication Administration Record

Secondary outcome measures

Length of stay

Rhodes index

Trial Design

1Treatment groups

Experimental Treatment

Group I: AromatherapyExperimental Treatment1 Intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Methodist Health SystemLead Sponsor

152 Previous Clinical Trials

4,825,583 Total Patients Enrolled

Ashley Attaway, RNPrincipal InvestigatorMethodist Mansfield Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the cut-off age for this trial greater than thirty years?

"The inclusion criteria of this clinical trial specifies that patients must be aged 18-65 to qualify for enrollment."

Answered by AI

Is there an opportunity to join this research endeavor?

"To become part of this medical trial, candidates must be between 18 and 65 years old and have experienced postoperative nausea. This study is looking for approximately 50 participants."

Answered by AI

What is the cap on participant numbers for this medical study?

"Affirmative. The information on clinicaltrials.gov suggests that this investigation is currently enrolling volunteers, with the trial being initially posted up in December 23rd 2020 and last modified on October 30th 2023. A total of 50 individuals are needed to participate across a single location."

Answered by AI

Are there any opportunities to participate in this experiment at the moment?

"Correct. The information posted on clinicaltrials.gov affirms that this medical study, which was initially published on December 23rd 2020 is currently enrolling patients. Approximately 50 participants are required from 1 distinct research centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient

2020. "Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06110416.